25 XP   0   0   10

Biovie Inc
Buy, Hold or Sell?

Let's analyse Biovie Inc together

PenkeI guess you are interested in Biovie Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biovie Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biovie Inc

I send you an email if I find something interesting about Biovie Inc.

Quick analysis of Biovie Inc (30 sec.)










What can you expect buying and holding a share of Biovie Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
$0.28
Expected worth in 1 year
$1.13
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$0.85
Return On Investment
173.3%

For what price can you sell your share?

Current Price per Share
$0.49
Expected price per share
$0.445 - $0.8902
How sure are you?
50%

1. Valuation of Biovie Inc (5 min.)




Live pricePrice per Share (EOD)

$0.49

Intrinsic Value Per Share

$-11.78 - $-8.76

Total Value Per Share

$-11.50 - $-8.48

2. Growth of Biovie Inc (5 min.)




Is Biovie Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$15.3m$3.6m$11.6m76.1%

How much money is Biovie Inc making?

Current yearPrevious yearGrowGrow %
Making money-$50.2m-$22.7m-$27.4m-54.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Biovie Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#696 / 1007

Most Revenue
#881 / 1007

Most Profit
#593 / 1007

Most Efficient
#317 / 1007

What can you expect buying and holding a share of Biovie Inc? (5 min.)

Welcome investor! Biovie Inc's management wants to use your money to grow the business. In return you get a share of Biovie Inc.

What can you expect buying and holding a share of Biovie Inc?

First you should know what it really means to hold a share of Biovie Inc. And how you can make/lose money.

Speculation

The Price per Share of Biovie Inc is $0.4904. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biovie Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biovie Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.28. Based on the TTM, the Book Value Change Per Share is $0.21 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biovie Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.91-186.6%-0.91-186.6%-0.47-96.8%-1.08-220.1%-0.55-111.8%
Usd Book Value Change Per Share0.2143.3%0.2143.3%-0.03-5.1%0.0611.3%0.035.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.2652.5%0.1326.3%
Usd Total Gains Per Share0.2143.3%0.2143.3%-0.03-5.1%0.3163.8%0.1632.0%
Usd Price Per Share4.31-4.31-1.45-7.36-3.80-
Price to Earnings Ratio-4.71--4.71--3.05--7.58--19.85-
Price-to-Total Gains Ratio20.29-20.29--57.74--28.16--13.54-
Price to Book Ratio15.43-15.43-21.69-37.68-6.56-
Price-to-Total Gains Ratio20.29-20.29--57.74--28.16--13.54-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.4904
Number of shares2039
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.26
Usd Book Value Change Per Share0.210.06
Usd Total Gains Per Share0.210.31
Gains per Quarter (2039 shares)433.21638.34
Gains per Year (2039 shares)1,732.832,553.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101733172321014522543
203466345642029055096
3051995189630313577649
40693169228404180910202
508664865510505226112755
60103971038812606271415308
70121301212114708316617861
80138631385416809361820414
90155961558718910407122967
100173281732021011452325520

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%5.05.00.050.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%3.00.07.030.0%3.00.07.030.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%5.05.00.050.0%

Fundamentals of Biovie Inc

About Biovie Inc

BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Fundamental data was last updated by Penke on 2024-05-02 12:00:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Biovie Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biovie Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biovie Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--216.8%+216.8%
YOY--282.4%+282.4%
5Y--426.4%+426.4%
10Y--589.3%+589.3%
1.1.2. Return on Assets

Shows how efficient Biovie Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • -143.2% Return on Assets means that Biovie Inc generated $-1.43 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biovie Inc:

  • The MRQ is -143.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -143.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-143.2%TTM-143.2%0.0%
TTM-143.2%YOY-113.3%-29.8%
TTM-143.2%5Y-708.4%+565.2%
5Y-708.4%10Y-390.8%-317.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-143.2%-13.0%-130.2%
TTM-143.2%-12.5%-130.7%
YOY-113.3%-11.2%-102.1%
5Y-708.4%-13.6%-694.8%
10Y-390.8%-15.2%-375.6%
1.1.3. Return on Equity

Shows how efficient Biovie Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • -327.6% Return on Equity means Biovie Inc generated $-3.28 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biovie Inc:

  • The MRQ is -327.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -327.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-327.6%TTM-327.6%0.0%
TTM-327.6%YOY-621.0%+293.4%
TTM-327.6%5Y-730.2%+402.6%
5Y-730.2%10Y-614.6%-115.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-327.6%-16.6%-311.0%
TTM-327.6%-15.7%-311.9%
YOY-621.0%-14.2%-606.8%
5Y-730.2%-18.9%-711.3%
10Y-614.6%-19.9%-594.7%

1.2. Operating Efficiency of Biovie Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biovie Inc is operating .

  • Measures how much profit Biovie Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biovie Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--285.4%+285.4%
TTM--226.2%+226.2%
YOY--288.4%+288.4%
5Y--469.6%+469.6%
10Y--599.3%+599.3%
1.2.2. Operating Ratio

Measures how efficient Biovie Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biovie Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.303-3.303
YOY-3.763-3.763
5Y-5.586-5.586
10Y-7.464-7.464

1.3. Liquidity of Biovie Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biovie Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.35 means the company has $2.35 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biovie Inc:

  • The MRQ is 2.349. The company is able to pay all its short-term debts. +1
  • The TTM is 2.349. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.349TTM2.3490.000
TTM2.349YOY4.504-2.156
TTM2.3495Y2.602-0.254
5Y2.60210Y1.611+0.991
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3493.855-1.506
TTM2.3494.160-1.811
YOY4.5045.323-0.819
5Y2.6026.122-3.520
10Y1.6116.480-4.869
1.3.2. Quick Ratio

Measures if Biovie Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • A Quick Ratio of 3.34 means the company can pay off $3.34 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biovie Inc:

  • The MRQ is 3.340. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.340. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.340TTM3.3400.000
TTM3.340YOY4.471-1.131
TTM3.3405Y2.622+0.719
5Y2.62210Y1.619+1.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3403.506-0.166
TTM3.3404.001-0.661
YOY4.4715.390-0.919
5Y2.6226.127-3.505
10Y1.6196.488-4.869

1.4. Solvency of Biovie Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biovie Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biovie Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.56 means that Biovie Inc assets are financed with 56.3% credit (debt) and the remaining percentage (100% - 56.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biovie Inc:

  • The MRQ is 0.563. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.563. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.563TTM0.5630.000
TTM0.563YOY0.817-0.254
TTM0.5635Y2.607-2.044
5Y2.60710Y1.647+0.959
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5630.344+0.219
TTM0.5630.339+0.224
YOY0.8170.275+0.542
5Y2.6070.368+2.239
10Y1.6470.389+1.258
1.4.2. Debt to Equity Ratio

Measures if Biovie Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 128.8% means that company has $1.29 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biovie Inc:

  • The MRQ is 1.288. The company is able to pay all its debts with equity. +1
  • The TTM is 1.288. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.288TTM1.2880.000
TTM1.288YOY4.479-3.191
TTM1.2885Y1.235+0.054
5Y1.23510Y2.714-1.479
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2880.390+0.898
TTM1.2880.408+0.880
YOY4.4790.341+4.138
5Y1.2350.438+0.797
10Y2.7140.469+2.245

2. Market Valuation of Biovie Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biovie Inc generates.

  • Above 15 is considered overpriced but always compare Biovie Inc to the Biotechnology industry mean.
  • A PE ratio of -4.71 means the investor is paying $-4.71 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biovie Inc:

  • The EOD is -0.536. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.710. Based on the earnings, the company is expensive. -2
  • The TTM is -4.710. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.536MRQ-4.710+4.174
MRQ-4.710TTM-4.7100.000
TTM-4.710YOY-3.053-1.657
TTM-4.7105Y-7.581+2.871
5Y-7.58110Y-19.846+12.265
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.536-2.351+1.815
MRQ-4.710-2.599-2.111
TTM-4.710-2.762-1.948
YOY-3.053-4.025+0.972
5Y-7.581-6.305-1.276
10Y-19.846-6.538-13.308
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biovie Inc:

  • The EOD is -0.669. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.881. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.881. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.669MRQ-5.881+5.212
MRQ-5.881TTM-5.8810.000
TTM-5.881YOY-4.194-1.687
TTM-5.8815Y-114.740+108.859
5Y-114.74010Y-101.431-13.309
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.669-3.010+2.341
MRQ-5.881-3.306-2.575
TTM-5.881-3.607-2.274
YOY-4.194-5.524+1.330
5Y-114.740-8.299-106.441
10Y-101.431-8.910-92.521
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biovie Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 15.43 means the investor is paying $15.43 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biovie Inc:

  • The EOD is 1.756. Based on the equity, the company is underpriced. +1
  • The MRQ is 15.432. Based on the equity, the company is expensive. -2
  • The TTM is 15.432. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1.756MRQ15.432-13.676
MRQ15.432TTM15.4320.000
TTM15.432YOY21.695-6.263
TTM15.4325Y37.681-22.249
5Y37.68110Y6.556+31.125
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.7562.019-0.263
MRQ15.4322.116+13.316
TTM15.4322.099+13.333
YOY21.6952.873+18.822
5Y37.6813.556+34.125
10Y6.5563.946+2.610
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biovie Inc.

3.1. Institutions holding Biovie Inc

Institutions are holding 4.498% of the shares of Biovie Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc0.6406035185015203476.087
2023-12-31BlackRock Inc0.63810350476278757388.6794
2023-12-31Geode Capital Management, LLC0.341501875894917535.5275
2023-12-31State Street Corporation0.3201757438637596.6509
2023-12-31Northern Trust Corp0.1983010892267932165.7282
2023-12-31Morgan Stanley - Brokerage Accounts0.15120830252769850.0624
2023-12-31Nuveen Asset Management, LLC0.1469080705810911.17
2023-12-31HPM Partners LLC0.07420.000240741510014.3094
2023-12-31Millennium Management LLC0.0673036962-22338-37.6695
2023-12-31Bank of America Corp0.066403645427844323.3914
2023-12-31Charles Schwab Investment Management Inc0.054502993518328157.9047
2023-12-31GRT Capital Partners LLC0.05360.03022945000
2023-12-31Virtu Financial LLC0.04570.002525077250770
2023-12-31Envestnet Asset Management Inc0.0399021911219110
2023-12-31Susquehanna International Group, LLP0.0355019503783167.0922
2023-12-31Crescent Grove Advisors, LLC0.03550.002719500850077.2727
2023-12-31Engineers Gate Manager LP0.03470.000719039190390
2023-12-31Atlantic Trust Group, LLC0.03240.00011781400
2023-12-31Barclays PLC0.0321017621165391528.5582
2023-12-31New York State Common Retirement Fund0.031401723500
Total 3.03980.03641669552+797911+47.8%

3.2. Funds holding Biovie Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Belfund SICAV Belinvest Equity A USD Acc0.76070.550141781200
2024-03-31Vanguard Total Stock Mkt Idx Inv0.7557041508900
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr0.26880.000114763700
2024-03-31State St Russell Sm/Mid Cp® Indx NL Cl C0.20760.000111400000
2024-01-31Fidelity Small Cap Index0.20280.00051114093796351.6883
2024-03-28iShares Russell 2000 Growth ETF0.19110.0005104937-122-0.1161
2024-02-29TIAA-CREF Equity Index Instl0.13220.00027259600
2024-03-31Vanguard Russell 2000 ETF0.08330.00024573515103.4144
2024-02-29Fidelity Extended Market Index0.07890.000143319-210-0.4824
2024-03-31Russell 2000 Index Non-Lendable Fund E0.06580.0004361172330.6493
2023-09-30BlackRock Extended Mkt Composite0.05750.000831570580.1841
2024-03-31Schwab Small Cap Index0.05450.00032993500
2023-12-31NT R2000 Growth Index Fund - L0.05190.00132848721432303.7845
2023-12-31Northern Trust Russell 2000 Growth Index0.05190.00132848721432303.7845
2024-03-28iShares Micro-Cap ETF0.04750.00152610000
2024-02-29Fidelity Nasdaq Composite Index0.04150.00022279800
2024-03-31BlackRock Russell 2000® Index NL F0.03650.000420074-807-3.8648
2024-02-29Fidelity Total Market Index0.033801854100
2024-03-31Northern Small Cap Index0.03150.000817322762978.7063
2024-02-29EQ/2000 Managed Volatility IB0.02720.00061492700
Total 3.18070.55941746892+89118+5.1%

3.3. Insider Transactions

Insiders are holding 43.253% of the shares of Biovie Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-30Cuong V DoBUY100001.78
2023-09-05Steve GorlinSELL85603.05
2023-08-22Richard J BermanSELL108053.5
2023-06-07Richard J BermanSELL59845.81
2023-05-22Richard J BermanSELL50006.5

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Biovie Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2120.2120%-0.025+112%0.055+283%0.028+661%
Book Value Per Share--0.2790.2790%0.067+318%0.017+1534%0.015+1819%
Current Ratio--2.3492.3490%4.504-48%2.602-10%1.611+46%
Debt To Asset Ratio--0.5630.5630%0.817-31%2.607-78%1.647-66%
Debt To Equity Ratio--1.2881.2880%4.479-71%1.235+4%2.714-53%
Dividend Per Share----0%-0%0.258-100%0.129-100%
Eps---0.915-0.9150%-0.475-48%-1.080+18%-0.548-40%
Free Cash Flow Per Share---0.733-0.7330%-0.346-53%-0.269-63%-0.137-81%
Free Cash Flow To Equity Per Share--0.2750.2750%0.257+7%0.123+124%0.061+355%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---8.764--------
Intrinsic Value_10Y_min---11.778--------
Intrinsic Value_1Y_max---0.401--------
Intrinsic Value_1Y_min---0.620--------
Intrinsic Value_3Y_max---1.569--------
Intrinsic Value_3Y_min---2.359--------
Intrinsic Value_5Y_max---3.175--------
Intrinsic Value_5Y_min---4.629--------
Market Cap26935023.840-779%236725026.000236725026.0000%79640670.000+197%404409829.800-41%208817836.740+13%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1.756-779%15.43215.4320%21.695-29%37.681-59%6.556+135%
Pe Ratio-0.536+89%-4.710-4.7100%-3.053-35%-7.581+61%-19.846+321%
Price Per Share0.490-779%4.3104.3100%1.450+197%7.363-41%3.802+13%
Price To Free Cash Flow Ratio-0.669+89%-5.881-5.8810%-4.194-29%-114.740+1851%-101.431+1625%
Price To Total Gains Ratio2.308-779%20.28620.2860%-57.737+385%-28.159+239%-13.536+167%
Quick Ratio--3.3403.3400%4.471-25%2.622+27%1.619+106%
Return On Assets---1.432-1.4320%-1.133-21%-7.084+395%-3.908+173%
Return On Equity---3.276-3.2760%-6.210+90%-7.302+123%-6.146+88%
Total Gains Per Share--0.2120.2120%-0.025+112%0.313-32%0.157+36%
Usd Book Value--15340286.00015340286.0000%3670935.000+318%938761.400+1534%799553.300+1819%
Usd Book Value Change Per Share--0.2120.2120%-0.025+112%0.055+283%0.028+661%
Usd Book Value Per Share--0.2790.2790%0.067+318%0.017+1534%0.015+1819%
Usd Dividend Per Share----0%-0%0.258-100%0.129-100%
Usd Eps---0.915-0.9150%-0.475-48%-1.080+18%-0.548-40%
Usd Free Cash Flow---40252881.000-40252881.0000%-18990850.000-53%-14765316.600-63%-7547338.500-81%
Usd Free Cash Flow Per Share---0.733-0.7330%-0.346-53%-0.269-63%-0.137-81%
Usd Free Cash Flow To Equity Per Share--0.2750.2750%0.257+7%0.123+124%0.061+355%
Usd Market Cap26935023.840-779%236725026.000236725026.0000%79640670.000+197%404409829.800-41%208817836.740+13%
Usd Price Per Share0.490-779%4.3104.3100%1.450+197%7.363-41%3.802+13%
Usd Profit---50255815.000-50255815.0000%-22797050.000-55%-45540721.600-9%-23243422.900-54%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--0.2120.2120%-0.025+112%0.313-32%0.157+36%
 EOD+2 -6MRQTTM+0 -0YOY+19 -105Y+16 -1510Y+19 -12

4.2. Fundamental Score

Let's check the fundamental score of Biovie Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.536
Price to Book Ratio (EOD)Between0-11.756
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.340
Current Ratio (MRQ)Greater than12.349
Debt to Asset Ratio (MRQ)Less than10.563
Debt to Equity Ratio (MRQ)Less than11.288
Return on Equity (MRQ)Greater than0.15-3.276
Return on Assets (MRQ)Greater than0.05-1.432
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Biovie Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.064
Ma 20Greater thanMa 500.488
Ma 50Greater thanMa 1000.665
Ma 100Greater thanMa 2000.941
OpenGreater thanClose0.500
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets35,105
Total Liabilities19,764
Total Stockholder Equity15,340
 As reported
Total Liabilities 19,764
Total Stockholder Equity+ 15,340
Total Assets = 35,105

Assets

Total Assets35,105
Total Current Assets34,041
Long-term Assets1,064
Total Current Assets
Cash And Cash Equivalents 19,461
Short-term Investments 14,478
Other Current Assets 103
Total Current Assets  (as reported)34,041
Total Current Assets  (calculated)34,041
+/-0
Long-term Assets
Property Plant Equipment 81
Goodwill 346
Intangible Assets 637
Long-term Assets  (as reported)1,064
Long-term Assets  (calculated)1,064
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities14,495
Long-term Liabilities5,270
Total Stockholder Equity15,340
Total Current Liabilities
Short-term Debt 9,150
Short Long Term Debt 9,105
Accounts payable 3
Other Current Liabilities 5,345
Total Current Liabilities  (as reported)14,495
Total Current Liabilities  (calculated)23,603
+/- 9,109
Long-term Liabilities
Long term Debt 5,227
Capital Lease Obligations 87
Long-term Liabilities  (as reported)5,270
Long-term Liabilities  (calculated)5,315
+/- 45
Total Stockholder Equity
Common Stock4
Retained Earnings -301,226
Accumulated Other Comprehensive Income 177
Other Stockholders Equity 316,386
Total Stockholder Equity (as reported)15,340
Total Stockholder Equity (calculated)15,340
+/-0
Other
Capital Stock4
Cash and Short Term Investments 33,939
Common Stock Shares Outstanding 32,483
Current Deferred Revenue-3
Liabilities and Stockholders Equity 35,105
Net Debt -5,041
Net Invested Capital 29,673
Net Tangible Assets 14,357
Net Working Capital 19,546
Property Plant and Equipment Gross 81
Short Long Term Debt Total 14,420



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-30
> Total Assets 
506
333
269
2,719
2,364
2,175
2,574
2,084
6,047
20,115
35,105
35,10520,1156,0472,0842,5742,1752,3642,719269333506
   > Total Current Assets 
506
333
269
131
5
46
674
413
4,605
18,780
34,041
34,04118,7804,605413674465131269333506
       Cash And Cash Equivalents 
506
333
267
124
5
46
340
37
4,512
18,642
19,461
19,46118,6424,51237340465124267333506
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
14,478
14,4780000000000
       Other Current Assets 
0
0
2
7
0
0
334
376
93
138
103
10313893376334007200
   > Long-term Assets 
0
0
0
2,588
2,359
2,130
1,900
1,671
1,442
1,335
1,064
1,0641,3351,4421,6711,9002,1302,3592,588000
       Property Plant Equipment 
0
0
0
2,588
0
0
0
0
0
118
81
81118000002,588000
       Goodwill 
0
0
0
346
346
346
346
346
346
346
346
346346346346346346346346000
       Intangible Assets 
0
0
0
2,243
2,013
1,784
1,555
1,325
1,096
866
637
6378661,0961,3251,5551,7842,0132,243000
       Other Assets 
0
0
0
0
0
0
0
0
0
5
0
05000000000
> Total Liabilities 
15
161
324
803
1,207
2,064
443
23,583
996
16,444
19,764
19,76416,44499623,5834432,0641,20780332416115
   > Total Current Liabilities 
15
161
324
803
631
1,238
443
23,520
996
4,169
14,495
14,4954,16999623,5204431,23863180332416115
       Short-term Debt 
0
0
0
0
0
0
0
849
0
39
9,150
9,1503908490000000
       Short Long Term Debt 
0
0
0
0
0
0
0
849
0
0
9,105
9,105008490000000
       Accounts payable 
15
0
1
294
471
884
443
1,259
996
2
3
329961,2594438844712941015
       Other Current Liabilities 
0
161
323
510
160
354
0
21,412
996
4,130
5,345
5,3454,13099621,41203541605103231610
   > Long-term Liabilities 
15
0
1
0
576
826
443
63
0
12,274
5,270
5,27012,27406344382657601015
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
12,139
0
012,139000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
48
0
048000000000
> Total Stockholder Equity
491
171
-54
1,916
1,157
111
2,131
-21,499
5,050
3,671
15,340
15,3403,6715,050-21,4992,1311111,1571,916-54171491
   Common Stock
9
9
9
9
9
10
51
1
2
2
4
4221511099999
   Retained Earnings -301,226-250,970-224,885-41,038-7,262-4,769-2,335-1,004-572-339-18
   Capital Surplus 
0
0
0
0
0
0
0
0
0
254,638
0
0254,638000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
500
502
510
2,912
3,483
4,870
9,342
19,539
229,934
254,638
316,386
316,386254,638229,93419,5399,3424,8703,4832,912510502500



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-267
Gross Profit-267-267
 
Operating Income (+$)
Gross Profit-267
Operating Expense-45,080
Operating Income-45,080-45,347
 
Operating Expense (+$)
Research Development33,300
Selling General Administrative11,552
Selling And Marketing Expenses0
Operating Expense45,08044,851
 
Net Interest Income (+$)
Interest Income562
Interest Expense-4,300
Other Finance Cost-0
Net Interest Income-3,738
 
Pretax Income (+$)
Operating Income-45,080
Net Interest Income-3,738
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-50,256-43,643
EBIT - interestExpense = -48,818
-45,956
-45,956
Interest Expense4,300
Earnings Before Interest and Taxes (EBIT)-44,518-45,956
Earnings Before Interest and Taxes (EBITDA)-44,289
 
After tax Income (+$)
Income Before Tax-50,256
Tax Provision-0
Net Income From Continuing Ops-50,256-50,256
Net Income-50,256
Net Income Applicable To Common Shares-50,256
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses45,080
Total Other Income/Expenses Net-1,4373,738
 

Technical Analysis of Biovie Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biovie Inc. The general trend of Biovie Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biovie Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biovie Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.524 < 0.5499 < 0.8902.

The bearish price targets are: 0.4521 > 0.445.

Tweet this
Biovie Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biovie Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biovie Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biovie Inc. The current macd is -0.03915251.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biovie Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biovie Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biovie Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biovie Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiovie Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biovie Inc. The current adx is 6.44097003.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biovie Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Biovie Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biovie Inc. The current sar is 0.5288453.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biovie Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biovie Inc. The current rsi is 40.06. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Biovie Inc Daily Relative Strength Index (RSI) ChartBiovie Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biovie Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biovie Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biovie Inc Daily Stochastic Oscillator ChartBiovie Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biovie Inc. The current cci is 45.74.

Biovie Inc Daily Commodity Channel Index (CCI) ChartBiovie Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biovie Inc. The current cmo is -12.3252974.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biovie Inc Daily Chande Momentum Oscillator (CMO) ChartBiovie Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biovie Inc. The current willr is -46.73157163.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biovie Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biovie Inc Daily Williams %R ChartBiovie Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biovie Inc.

Biovie Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biovie Inc. The current atr is 0.04694705.

Biovie Inc Daily Average True Range (ATR) ChartBiovie Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biovie Inc. The current obv is 44,340,834.

Biovie Inc Daily On-Balance Volume (OBV) ChartBiovie Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biovie Inc. The current mfi is 61.38.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Biovie Inc Daily Money Flow Index (MFI) ChartBiovie Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biovie Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Biovie Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biovie Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.064
Ma 20Greater thanMa 500.488
Ma 50Greater thanMa 1000.665
Ma 100Greater thanMa 2000.941
OpenGreater thanClose0.500
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biovie Inc with someone you think should read this too:
  • Are you bullish or bearish on Biovie Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biovie Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biovie Inc

I send you an email if I find something interesting about Biovie Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biovie Inc.

Receive notifications about Biovie Inc in your mailbox!